Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,936 | 486 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,782 | 95 | $0 (2024) |
| Amgen Inc. | $1,469 | 37 | $0 (2024) |
| Lilly USA, LLC | $917.36 | 62 | $0 (2024) |
| GlaxoSmithKline, LLC. | $883.49 | 51 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $743.82 | 19 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $716.50 | 42 | $0 (2024) |
| ABBVIE INC. | $705.20 | 49 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $517.11 | 22 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $342.99 | 18 | $0 (2024) |
| Amarin Pharma Inc. | $163.05 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,204 | 69 | Lilly USA, LLC ($246.89) |
| 2023 | $1,423 | 83 | GlaxoSmithKline, LLC. ($365.62) |
| 2022 | $2,663 | 106 | Janssen Pharmaceuticals, Inc ($521.55) |
| 2021 | $2,187 | 101 | Novo Nordisk Inc ($511.05) |
| 2020 | $1,343 | 56 | Novo Nordisk Inc ($493.22) |
| 2019 | $1,977 | 62 | Novo Nordisk Inc ($970.59) |
| 2018 | $139.80 | 9 | Novo Nordisk Inc ($86.88) |
All Payment Transactions
486 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Inflammation | ||||||
| 12/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $1.44 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Obesity | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: PAIN | ||||||
| 10/02/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $41.05 | General |
| Category: Durable Pump | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 221 | 329 | $58,905 | $22,927 |
| 2022 | 8 | 219 | 302 | $47,730 | $20,789 |
| 2021 | 7 | 173 | 232 | $38,010 | $17,316 |
| 2020 | 3 | 46 | 64 | $6,885 | $2,458 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 135 | $32,400 | $13,330 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 67 | $11,055 | $4,173 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $6,320 | $2,174 | 34.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $1,620 | $1,219 | 75.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 13 | 17 | $3,740 | $974.14 | 26.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $1,330 | $645.43 | 48.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 23 | $1,610 | $269.85 | 16.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $720.00 | $117.90 | 16.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 16 | 22 | $110.00 | $23.86 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 110 | $26,400 | $12,416 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 50 | $8,250 | $3,385 | 41.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $7,505 | $2,826 | 37.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 14 | 14 | $1,260 | $959.56 | 76.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $1,050 | $505.35 | 48.1% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2022 | 26 | 34 | $1,700 | $367.59 | 21.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 21 | 23 | $1,380 | $223.28 | 16.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 28 | 37 | $185.00 | $106.50 | 57.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 47 | $11,280 | $5,966 | 52.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 71 | $11,715 | $5,750 | 49.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 25 | 25 | $9,875 | $3,787 | 38.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 13 | 13 | $910.00 | $848.38 | 93.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2021 | 32 | 47 | $2,350 | $484.33 | 20.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 14 | 14 | $980.00 | $273.42 | 27.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 13 | 15 | $900.00 | $206.40 | 22.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 31 | $5,115 | $2,071 | 40.5% |
About Dr. Maria Paschalidis, D.O
Dr. Maria Paschalidis, D.O is a Family Medicine healthcare provider based in Union City, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2013. The National Provider Identifier (NPI) number assigned to this provider is 1053748178.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maria Paschalidis, D.O has received a total of $10,936 in payments from pharmaceutical and medical device companies, with $1,204 received in 2024. These payments were reported across 486 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($10,936).
As a Medicare-enrolled provider, Paschalidis has provided services to 659 Medicare beneficiaries, totaling 927 services with total Medicare billing of $63,491. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Union City, NJ
- Active Since 10/03/2013
- Last Updated 09/11/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1053748178
Products in Payments
- Ozempic (Drug) $1,513
- JARDIANCE (Drug) $818.71
- TRELEGY ELLIPTA (Drug) $736.49
- XARELTO (Drug) $725.26
- Aimovig (Biological) $555.87
- Saxenda (Drug) $350.55
- MOUNJARO (Drug) $340.62
- UBRELVY (Drug) $328.17
- NURTEC ODT (Drug) $316.77
- FARXIGA (Drug) $305.36
- Otezla (Drug) $292.99
- Repatha (Biological) $261.37
- RYBELSUS (Drug) $260.21
- Prolia (Biological) $224.37
- TRULICITY (Drug) $218.40
- XIFAXAN (Drug) $216.23
- Rybelsus (Drug) $193.70
- LINZESS (Drug) $178.90
- EMGALITY (Drug) $166.44
- Vascepa (Drug) $163.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Union City
Dr. Jerry Jurado, M.d, M.D
Family Medicine — Payments: $63,292
Francisco Gonzalez, Md, MD
Family Medicine — Payments: $14,250
John Clendenin, M.d, M.D
Family Medicine — Payments: $11,619
John Hale, M.d, M.D
Family Medicine — Payments: $11,378
William Stone, M.d, M.D
Family Medicine — Payments: $11,291
Dr. Rogelio Allanigue, M.d, M.D
Family Medicine — Payments: $9,223